exenatide glp 1 agonist GLP-1 Agonists: A Comprehensive Overview Amneal Launches GLP-1 Agonist Exenatide
Description
For REDEFINE-2, CagriSema (2.4 mg/2.4 mg) is compared to placebo, with mean weight loss results of 13.7% and 3.4%, respectively (77)
Nutrients 2022;14:209
Continual administration of semaglutide led to 15% reduction in body weight at 68 weeks, along with improvements in cardiovascular risk and overall physiological condition [9]
Water intake has risen significantly after using weight loss drugs Change in water intake "I drink a lot more water since starting my GLP-1," Ella explained
References Ahmed M, Cerda I, Maloof M
2019;68:1006P
